The logo for AstraZeneca is seen outside its North America headquarters in Wilmington, Delaware, U.S., March 22, 2021. REUTERS/Rachel Wisniewski/File Photoon Thursday struck a deal with the firm behind Imperial College London's experimental COVID-19 vaccine to develop and sell drugs based on its self-amplifying RNA technology platform in other disease areas.
Under the deal, VaxEquity, a startup founded by Imperial vaccinologist Robin Shattock, could receive up to $195 million if certain milestones are met, in addition to royalties on approved drugs and equity investment from AstraZeneca and life sciences investor Morningside Ventures. AstraZeneca already produces an adenoviral vector COVID-19 vaccine, and emphasised the potential of the self-amplifying RNA technology in novel therapeutic programmes beyond the coronavirus pandemic.
"This collaboration with VaxEquity adds a promising new platform to our drug discovery toolbox," said AstraZeneca research chief Mene Pangalos.
With all the $$$ it has claimed with this whole scam, what else will they spend money on.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: NASA - 🏆 672. / 51 Read more »
Source: washingtonpost - 🏆 95. / 72 Read more »
Source: HuffPostWomen - 🏆 27. / 68 Read more »
Source: ELLE Magazine (US) - 🏆 472. / 51 Read more »
Source: PsychToday - 🏆 714. / 51 Read more »